You are here

  • Home
  • Archive
  • Volume 47, Issue 9
  • Novel drug candidates targeting Alzheimer’s disease: ethical challenges with identifying the relevant patient population

Article info

Article menu
XML
Feature article
Novel drug candidates targeting Alzheimer’s disease: ethical challenges with identifying the relevant patient population

Authors

  1. Correspondence to Erik Gustavsson, Centre for Applied Ethics, Department of Culture and Society, Linköping University, Linköping 581 83, Sweden; erik.gustavsson{at}liu.se
View Full Text

Citation

Gustavsson E, Raaschou P, Lärfars G, et al
Novel drug candidates targeting Alzheimer’s disease: ethical challenges with identifying the relevant patient population
Journal of Medical Ethics 2021;47:608-614.

Publication history

  • Received February 4, 2021
  • Accepted May 26, 2021
  • First published June 11, 2021.
Online issue publication 
January 18, 2022

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.

Other content recommended for you